Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 known ✓ | P13945 | 1/20 | 0.42 |
| ▸ | OPRD1 known ✓ | P41143 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 12/20 | 0.65 |
| ▸ | RARG | P13631 | 1/20 | 0.58 |
| ▸ | RXRA | P19793 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL4897996 | 0.99 | PPARG (0.64) | PPARGRARGRXRAMAPTALDH1A1 | |
| SCHEMBL602342 | 0.95 | PPARG (0.67) | PPARGRARGRXRAMAPTALDH1A1 | |
| SCHEMBL6606406 | 0.94 | PPARG (0.66) | PPARGRARGRXRAMAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL28341874 | 0.94 | PPARG (0.66) | PPARGRARGRXRAMAPTALDH1A1 | |
| Sulfuric Acid SCHEMBL3120275 | 0.93 | PPARG (0.65) | PPARGRARGRXRAMAPTALDH1A1 | |
| Fumaric Acid SCHEMBL3126673 | 0.90 | PPARG (0.72) | PPARGRARGRXRAMAPTALDH1A1 | |
| SCHEMBL1847231 | 0.85 | PPARG (0.53) | PPARGRARGRXRAMAPTALDH1A1 | |
| Rosiglitazone SCHEMBL4889277 | 0.83 | PPARG (0.92) | PPARGRARGRXRAMAPTALDH1A1 | |
| Rosiglitazone SCHEMBL4897990 | 0.82 | PPARG (0.91) | PPARGRARGRXRAMAPTALDH1A1 | |
| SCHEMBL9325005 | 0.81 | PPARG (0.48) | PPARGRARGRXRAPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080319024-A1 | Rosiglitazone Phosphate and Polymorphic Forms | GREIL JULIA | 2008-12-25 | — | — | US | claimed |
| EP-1735291-A2 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | Sandoz AG (CH) | 2006-12-27 | — | — | EP | claimed |
| WO-2005080358-A2 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | SANDOZ AG (CH) | 2005-09-01 | — | — | WO | claimed |
| US-20080319024-A1 | Rosiglitazone Phosphate and Polymorphic Forms | GREIL JULIA | 2008-12-25 | — | — | US | disclosed |
| US-20080319024-A1 | Rosiglitazone Phosphate and Polymorphic Forms | GREIL JULIA | 2008-12-25 | — | — | US | disclosed |
| CN-1964966-A | Rosiglitazone phosphate and polymorphic forms | SANDOZ AG (CH) | 2007-05-16 | — | — | CN | disclosed |
| WO-2005080358-A3 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | SANDOZ AG (CH) | 2006-12-28 | — | — | WO | disclosed |
| EP-1735291-A2 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | Sandoz AG (CH) | 2006-12-27 | — | — | EP | disclosed |
| EP-1735291-A2 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | Sandoz AG (CH) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005080358-A2 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | SANDOZ AG (CH) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005080358-A2 | ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS | SANDOZ AG (CH) | 2005-09-01 | — | — | WO | disclosed |